Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
NerdWallet A | NRDS | Nov 18, 2024 | 13.42 | -3.31 |
Nerdy A | NRDY | Nov 18, 2024 | 1.00 | +4.61 |
Net Lease Office Properties When Issued | NLOP | Nov 18, 2024 | 30.52 | -1.36 |
Net Power A | NPWR | Nov 18, 2024 | 12.40 | -2.13 |
NetApp | NTAP | Nov 18, 2024 | 119.34 | +1.82 |
Netcapital | NCPL | Nov 18, 2024 | 1.69 | -2.31 |
NetEase ADR | NTES | Nov 18, 2024 | 88.26 | +3.24 |
Netflix | NFLX | Nov 18, 2024 | 847.05 | +2.80 |
NETGEAR | NTGR | Nov 18, 2024 | 24.46 | +1.28 |
Netherlands Invstbl Mkt Idx MSCI Ishares | EWN | Nov 18, 2024 | 44.92 | +0.40 |
NetScout Systems | NTCT | Nov 18, 2024 | 21.69 | -0.78 |
NETSOL Technologies | NTWK | Nov 18, 2024 | 2.60 | -3.35 |
Netstreit | NTST | Nov 18, 2024 | 15.68 | +1.49 |
Network-1 Technologies | NTIP | Nov 18, 2024 | 1.33 | -1.48 |
Neuberger Berman | NML | Nov 18, 2024 | 9.02 | +1.12 |
Neuberger Berman High Yield Strategies Fund | NHS | Nov 18, 2024 | 7.71 | 0.00 |
Neuberger Berman Municipal Fund | NBH | Nov 18, 2024 | 10.67 | -0.09 |
Neuberger Berman Next Generation Connectivity Fund | NBXG | Nov 18, 2024 | 13.07 | +1.40 |
Neuberger Berman Real Estate Securities Income Fund | NRO | Nov 18, 2024 | 3.77 | +1.07 |
NeueHealth | NEUE | Nov 18, 2024 | 5.03 | +0.60 |
Neumora Therapeutics | NMRA | Nov 18, 2024 | 9.84 | -9.23 |
Neuraxis | NRXS | Nov 18, 2024 | 3.10 | -1.59 |
Neurobo Pharmaceuticals | NRBO | Nov 18, 2024 | 2.31 | +4.05 |
Neurocrine Biosciences | NBIX | Nov 18, 2024 | 117.62 | +0.15 |
Neurogene | NGNE | Nov 18, 2024 | 19.82 | -42.58 |
NeuroMetrix | NURO | Nov 18, 2024 | 3.80 | -3.31 |
Neuronetics | STIM | Nov 18, 2024 | 0.78 | +10.00 |
NeuroOne | NMTC | Nov 18, 2024 | 0.70 | -1.53 |
Neuropace | NPCE | Nov 18, 2024 | 8.95 | -0.33 |
NeuroSense Therapeutics | NRSN | Nov 18, 2024 | 1.18 | -4.07 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.